WaveMan
WaveMan · Company
PEN · Penumbra Inc
> Search tickers & screens ⌘K
LIVE
← All companies

PEN Penumbra (PEN) Insider Trading, Ownership & Congress Trades

Medical Devices · Surgical & medical instruments & apparatus · CIK 0001321732
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
192
13F, latest reported quarter

What the filings say about PEN

Congress, 1 year
No trades
Last one: sale, 2025-07-10

Penumbra insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for Penumbra Inc in the period covered. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Grewal Harpreet
Director
SELL
2026-04-06 SECtraded 2026-04-02
100
$32.8K
-1.7%
Context
  • 18 earlier Form 4 trades (code P or S) here by this insider (18 sales), the last on Jan 6, 2026.
  • The trade is 1.1% of the 8,719 shares held after it.
  • No other insider sold within 30 days.
  • 192 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Grewal Harpreet sold about $32.8K of PEN on Apr 2, 2026; 192 funds added in the latest 13F quarter.
Yuen Maggie
Chief Financial Officer
SELL
2026-03-04 SECtraded 2026-03-02
2,432
$832.5K
-4.8%
Context
  • 7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Aug 13, 2025.
  • The trade is 13.3% of the 18,353 shares held after it.
  • No other insider sold within 30 days.
  • 192 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Yuen Maggie sold about $832.5K of PEN on Mar 2, 2026; 192 funds added in the latest 13F quarter.
Grewal Harpreet
Director
SELL
2026-01-08 SECtraded 2026-01-06
186
$58.2K
+0.6%
Context
  • 17 earlier Form 4 trades (code P or S) here by this insider (17 sales), the last on Dec 2, 2025.
  • The trade is 2.3% of the 8,230 shares held after it.
  • 2 other insiders sold within 30 days.
  • 192 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Grewal Harpreet sold about $58.2K of PEN on Jan 6, 2026; 2 other insiders sold within 30 days and 192 funds added in the latest 13F quarter.
Wilder Thomas
Director
SELL
2026-01-06 SECtraded 2026-01-02
186
$57.8K
+2.6%
Context
  • 11 earlier Form 4 trades (code P or S) here by this insider (11 sales), the last on Oct 1, 2025.
  • 3 other insiders sold within 30 days.
  • 192 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Wilder Thomas sold about $57.8K of PEN on Jan 2, 2026; 3 other insiders sold within 30 days and 192 funds added in the latest 13F quarter.
Bose Arani
Director
SELL
2025-12-15 SECtraded 2025-12-11
2,030
$619.5K
+5.3%
Context
  • 56 earlier Form 4 trades (code P or S) here by this insider (56 sales), the last on Nov 25, 2025.
  • The trade is 0.7% of the 271,432 shares held after it.
  • 3 other insiders sold within 30 days.
  • 192 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Bose Arani sold about $619.5K of PEN on Dec 11, 2025; 3 other insiders sold within 30 days and 192 funds added in the latest 13F quarter.
695 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 690 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
192 funds bought in last quarter
more than 82% of Medical Devices
Revenue
+17.5% year over year
more than 68% of Medical Devices
Margin
12.7% net margin
more than 84% of Medical Devices
Buybacks
no share repurchases reported
Short interest
5.9% of the float short (float per yahoo 2026-10-26) · 4.8 days to cover · settled 2026-09-30
more than 68% of Medical Devices
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch PEN

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+28.7%12M
-11%+7%+25%+43%2025-102025-122026-022026-042026-062026-082026-10 2025-11-25 · Bose Arani sold $2.3M2025-11-21 · Bose Arani sold $2.1M2025-12-11 · Bose Arani sold $1.5M2025-12-11 · Bose Arani sold $1.1M2026-03-02 · Yuen Maggie sold $832.5K2025-12-11 · Bose Arani sold $646.5K2025-12-11 · Bose Arani sold $619.5K2025-12-11 · Bose Arani sold $591.6K2025-11-25 · Roberts Johanna sold $540.1K2025-12-11 · Bose Arani sold $159.7K2025-12-05 · Roberts Johanna sold $90.0K2026-01-06 · Grewal Harpreet sold $58.2K2026-01-02 · Wilder Thomas sold $57.8K2025-11-10 · Roberts Johanna sold $56.3K2025-11-21 · Bose Arani sold $47.2K2025-12-01 · Roberts Johanna sold $45.7K2025-11-10 · Roberts Johanna sold $44.7K2025-12-01 · Roberts Johanna sold $42.5K2025-11-04 · Grewal Harpreet sold $42.3K2026-04-02 · Grewal Harpreet sold $32.8K2025-12-02 · Grewal Harpreet sold $29.3K2025-12-01 · Roberts Johanna sold $27.5K2025-12-01 · Roberts Johanna sold $23.7K2025-12-01 · Roberts Johanna sold $23.2K2025-11-10 · Roberts Johanna sold $22.7K2025-11-10 · Roberts Johanna sold $20.4K2025-12-01 · Roberts Johanna sold $11.4K2025-11-10 · Roberts Johanna sold $9.7K2025-11-10 · Roberts Johanna sold $3.4K2025-12-01 · Roberts Johanna sold $3.0K2025-11-10 · Roberts Johanna sold $2.9K2025-12-11 · Bose Arani sold $1.2K
Insider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns PEN: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
4,297,555 sh
$1.4B
HBK INVESTMENTS L P
1,838,508 sh
$580.5M
VANGUARD CAPITAL MANAGEMENT LLC
1,709,877 sh
$539.9M
VANGUARD PORTFOLIO MANAGEMENT LLC
1,667,276 sh
$526.4M
STATE STREET CORP
1,243,258 sh
$392.6M

Congress trades in PEN

STOCK Act disclosures, US House only, filed up to 45 days after the trade
Lisa McClain
Sold 2025-07-10 · disclosed 34 days later
$1,001 - $15,000
All stocks members of Congress are buying · Every member's trades

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

PEN planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

PEN mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Return Stacked(R) Bonds & Merger Arbitrage ETF
$2.4M position · as of 2026-07-31
4.6%
Fidelity SAI Merger Arbitrage Fund
$25.7M position · as of 2026-07-31
4.0%
Water Island Event-Driven Fund
$1.9M position · as of 2026-05-31
3.8%
THE ARBITRAGE FUND
$30.3M position · as of 2026-05-31
3.6%
Motley Fool Small-Cap Growth ETF
$2.1M position · as of 2026-05-31
3.5%
StockSnips AI-Powered Sentiment US All Cap ETF
$669.7K position · as of 2026-07-31
3.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return · Adam Elsesser
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$851.6K
$851.6K
$2.9M
+78%
-22%
2024
$630.5K
$630.5K
$1.8M
+36%
-22%
2023
$601.6K
$601.6K
$622.6K
+44%
-26%
2022
$601.6K
$601.6K
$1.8M
+27%
-21%
2021
$497.8K
$497.8K
$1.3M
+64%
+3%
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 192 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
BLFSMTDSIBNWRBYISRGTXGDXCMEWTMDXOMIRMDLUNG

PEN financials

Revenue growth
+17.5%
XBRL, annual
Net margin
12.7%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.5B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+10.7%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$215.9M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
n/a
no debt line filed
Cash flow to debt
n/a
no debt line filed
Return on equity
+11.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+8.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
no debt line filed
Return on capital employed
+11.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
79.70x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
n/a
no debt line filed
FCF yield
+1.7%
TTM free cash flow over market value at close 2026-10-23
PEG, trailing
10.02x
P/E over trailing EPS growth of 8%: four quarters to 2026-06-30 against the four to 2025-06-30
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$1.4B$1.2B$1.1B$847.1M
Gross profit$942.4M$755.0M$682.6M$535.2M
Operating income$189.2M$9.3M$73.6M$6.1M
Net income$177.7M$14.0M$91.0M-$2.0M
EPS (diluted)4.520.362.32-0.05
Operating cash flow$238.7M$168.5M$97.3M-$55.7M
Cash$186.9M$324.4M$167.5M$69.9M
Buybacks$0$100.4M$0$0
SEC XBRL, fiscal years, as known on 2026-10-27

PEN Stock Sonar score 4/7 axes

Find similar shapesCompare

PEN ranks highest on profitability (84th percentile) and institutional and government (82nd), and lowest on risk and compliance (47th), among Medical Devices peers.

Profitability
84
Inputs
  • Return on equity+11.4% · 81 pct, sector of 183
  • Return on assets+8.8% · 85 pct, sector of 214
  • Return on invested capitalno debt line filed
  • Return on capital employed+11.5% · 84 pct, sector of 188
Growth
68
Inputs
  • Revenue growth, YoY+17.5% · 68 pct, sector of 219
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
82
Inputs
  • Funds adding, latest quarter192 · 82 pct, sector of 191
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
47
Inputs
  • Short interest, % of float+5.9% · 43 pct, sector of 240
  • Recalls per $1B revenue, 3y1.42 per $1B · 30 pct, sector of 116
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+7.7% · 68 pct, sector of 198
3 not measured: Financial health, Insider conviction, US patents
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

PEN filings, in plain words

Have members of Congress traded PEN?

Yes, but not in the year to 2026-10-27; the latest on record is a sale by Lisa McClain dated 2025-07-10.

Read the full summary

Members of Congress have disclosed trades in PEN, none in the last year; the latest on record is a sale by Lisa McClain dated 2025-07-10. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies